ID

31031

Beschreibung

ARI103094-Follow-Up Study for REDUCE Study Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00883909

Link

https://clinicaltrials.gov/show/NCT00883909

Stichworte

Versionen (1)
  1. 12.07.18 12.07.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

12. Juli 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Neoplasms, Prostate NCT00883909

Englisch

Eligibility Neoplasms, Prostate NCT00883909

1 Formulare  
Criteria
Beschreibung

Criteria

any subject who has participated in the reduce study and meets one of the following eligibility criteria is eligible for part a, 2 year observational follow-up study:
Beschreibung

Study Subject Participation Status | Criteria Fulfill

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0243161
UMLS CUI [2,2]
C1550543
completed 4 years on investigational product through the reduce 4 year study visit (visit 10) or
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
was diagnosed with prostate cancer during the reduce study, discontinued investigational product (ip) but participated in reduce prostate cancer follow-up visits through the 4 year study visit (visit 10p) or
Beschreibung

Prostate carcinoma | Investigational New Drugs Discontinued | Participation Follow-up

Datentyp

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C1444662
UMLS CUI [3,1]
C0679823
UMLS CUI [3,2]
C3274571
withdrew from reduce study visit participation and ip (for any reasons) but participated in reduce follow-up phone calls every 6 months through the 4 year phone call
Beschreibung

Participation Clinical Trial Visit Withdrawn | Investigational New Drugs Withdrawn | Participation Follow-up Telephone call

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C0008976
UMLS CUI [1,3]
C1512346
UMLS CUI [1,4]
C0424092
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0424092
UMLS CUI [3,1]
C0679823
UMLS CUI [3,2]
C3274571
UMLS CUI [3,3]
C0302186
exclusion criteria: part a subjects meeting the following criterion must not be enrolled in part a of the study
Beschreibung

Exclusion Criteria Part Roman letter

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0449719
UMLS CUI [1,3]
C0439102
inability/unwillingness to participate in the follow-up study phone calls.
Beschreibung

Participation Follow-up Telephone call Unable | Participation Follow-up Telephone call Unwilling

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C3274571
UMLS CUI [1,3]
C0302186
UMLS CUI [1,4]
C1299582
UMLS CUI [2,1]
C0679823
UMLS CUI [2,2]
C3274571
UMLS CUI [2,3]
C0302186
UMLS CUI [2,4]
C0558080
inclusion criteria: part b
Beschreibung

Inclusion criteria Part Roman letter

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0449719
UMLS CUI [1,3]
C0439102
subjects eligible for enrolment in part b of the study must meet the following criteria:
Beschreibung

Criteria Fulfill

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
any subject who was diagnosed with prostate cancer based on a prostate biopsy during participation in the reduce study, regardless of when their reduce study participation ended.
Beschreibung

Prostate carcinoma Biopsy of prostate

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0194804
exclusion criteria: part b
Beschreibung

Exclusion Criteria Part Roman letter

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0449719
UMLS CUI [1,3]
C0439102
the exclusion criterion only applies to part a, the 2 year observational follow-up study. there are no exclusion criteria for part b, prostate biopsy tissue study.
Beschreibung

Unspecified

Datentyp

boolean

Alias
UMLS CUI [1]
C0205370
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Neoplasms, Prostate NCT00883909

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Study Subject Participation Status | Criteria Fulfill
Item
any subject who has participated in the reduce study and meets one of the following eligibility criteria is eligible for part a, 2 year observational follow-up study:
boolean
C2348568 (UMLS CUI [1])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Investigational New Drugs
Item
completed 4 years on investigational product through the reduce 4 year study visit (visit 10) or
boolean
C0013230 (UMLS CUI [1])
Prostate carcinoma | Investigational New Drugs Discontinued | Participation Follow-up
Item
was diagnosed with prostate cancer during the reduce study, discontinued investigational product (ip) but participated in reduce prostate cancer follow-up visits through the 4 year study visit (visit 10p) or
boolean
C0600139 (UMLS CUI [1])
C0013230 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0679823 (UMLS CUI [3,1])
C3274571 (UMLS CUI [3,2])
Participation Clinical Trial Visit Withdrawn | Investigational New Drugs Withdrawn | Participation Follow-up Telephone call
Item
withdrew from reduce study visit participation and ip (for any reasons) but participated in reduce follow-up phone calls every 6 months through the 4 year phone call
boolean
C0679823 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C1512346 (UMLS CUI [1,3])
C0424092 (UMLS CUI [1,4])
C0013230 (UMLS CUI [2,1])
C0424092 (UMLS CUI [2,2])
C0679823 (UMLS CUI [3,1])
C3274571 (UMLS CUI [3,2])
C0302186 (UMLS CUI [3,3])
Exclusion Criteria Part Roman letter
Item
exclusion criteria: part a subjects meeting the following criterion must not be enrolled in part a of the study
boolean
C0680251 (UMLS CUI [1,1])
C0449719 (UMLS CUI [1,2])
C0439102 (UMLS CUI [1,3])
Participation Follow-up Telephone call Unable | Participation Follow-up Telephone call Unwilling
Item
inability/unwillingness to participate in the follow-up study phone calls.
boolean
C0679823 (UMLS CUI [1,1])
C3274571 (UMLS CUI [1,2])
C0302186 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
C0679823 (UMLS CUI [2,1])
C3274571 (UMLS CUI [2,2])
C0302186 (UMLS CUI [2,3])
C0558080 (UMLS CUI [2,4])
Inclusion criteria Part Roman letter
Item
inclusion criteria: part b
boolean
C1512693 (UMLS CUI [1,1])
C0449719 (UMLS CUI [1,2])
C0439102 (UMLS CUI [1,3])
Criteria Fulfill
Item
subjects eligible for enrolment in part b of the study must meet the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Prostate carcinoma Biopsy of prostate
Item
any subject who was diagnosed with prostate cancer based on a prostate biopsy during participation in the reduce study, regardless of when their reduce study participation ended.
boolean
C0600139 (UMLS CUI [1,1])
C0194804 (UMLS CUI [1,2])
Exclusion Criteria Part Roman letter
Item
exclusion criteria: part b
boolean
C0680251 (UMLS CUI [1,1])
C0449719 (UMLS CUI [1,2])
C0439102 (UMLS CUI [1,3])
Unspecified
Item
the exclusion criterion only applies to part a, the 2 year observational follow-up study. there are no exclusion criteria for part b, prostate biopsy tissue study.
boolean
C0205370 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video